z-logo
Premium
Machine learning and treatment outcome prediction for oral cancer
Author(s) -
Chu Chui S.,
Lee Nikki P.,
Adeoye John,
Thomson Peter,
Choi SiuWai
Publication year - 2020
Publication title -
journal of oral pathology and medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.887
H-Index - 83
eISSN - 1600-0714
pISSN - 0904-2512
DOI - 10.1111/jop.13089
Subject(s) - receiver operating characteristic , machine learning , decision tree , artificial intelligence , support vector machine , progressive disease , disease , medicine , bivariate analysis , outcome (game theory) , principal component analysis , oncology , computer science , mathematics , mathematical economics
Background The natural history of oral squamous cell carcinoma (OSCC) is complicated by progressive disease including loco‐regional tumour recurrence and development of distant metastases. Accurate prediction of tumour behaviour is crucial in delivering individualized treatment plans and developing optimal patient follow‐up and surveillance strategies. Machine learning algorithms may be employed in oncology research to improve clinical outcome prediction. Methods Retrospective review of 467 OSCC patients treated over a 19‐year period facilitated construction of a detailed clinicopathological database. 34 prognostic features from the database were used to populate 4 machine learning algorithms, linear regression (LR), decision tree (DT), support vector machine (SVM) and k‐nearest neighbours (KNN) models, to attempt progressive disease outcome prediction. Principal component analysis (PCA) and bivariate analysis were used to reduce data dimensionality and highlight correlated variables. Models were validated for accuracy, sensitivity and specificity, with predictive ability assessed by receiver operating characteristic (ROC) and area under the curve (AUC) calculation. Results Out of 408 fully characterized OSCC patients, 151 (37%) had died and 131 (32%) exhibited progressive disease at the time of data retrieval. The DT model with 34 prognostic features was most successful in identifying “true positive” progressive disease, achieving 70.59% accuracy (AUC 0.67), 41.98% sensitivity and a high specificity of 84.12%. Conclusion Machine learning models assist clinicians in accessing digitized health information and appear promising in predicting progressive disease outcomes. The future will see increasing emphasis on the use of artificial intelligence to enhance understanding of aggressive tumour behaviour, recurrence and disease progression.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here